Theraclion attends the European Society of Endocrine Surgeons congress (May 13-15, 2010) in Vienna. The company presents their latest technology, TH-One, an innovative and unique device dedicated to endocrine surgeons for the ablation of fine endocrine targets such as thyroid nodules and parathyroid adenomas.

ESES congress counts more than 300 participants. It is the largest endocrine surgery conference in Europe. Hence Theraclion’s participation to this event was an important milestone for the company in order to increase its exposure towards this community of physicians. David Del Bourgo, VP Marketing of Theraclion, described the exhibition as great success: “It is a great honor for us to be able to share our innovation with prominent surgeons. We attracted a lot of interest with more than 100 visits on our booth.TH-One is already installed in prestigious centers in Europe and we look forward to extending our activity among top-level centers”.

Our technology was mentionned during the Charles Proye Lecture  “Minimally Invasive Endocrine Surgery and the Future” by Prof. Paolo Miccoli, Pisa, Italy.

ESES website: http://www.eses.cc/

Read Previous News